Letter of Response Regarding Adrenal SABR to the Article Published in the March 2024 Journal Publication: Prospective Longitudinal Assessment of Quality of Life after Stereotactic Ablative Radiotherapy for Oligometastases: Analysis of the Population-based SABR-5 Phase II Trial by Cruz-Lim et al

Clin Oncol (R Coll Radiol). 2024 Jul;36(7):e239. doi: 10.1016/j.clon.2024.04.005. Epub 2024 Apr 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Clinical Trials, Phase II as Topic
  • Humans
  • Prospective Studies
  • Quality of Life*
  • Radiosurgery* / methods